- Home
- MRAM vs THTX Comparison
MRAM vs THTX Comparison
Compare MRAM & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- THTX
- Stock Information
- Founded
- MRAM 2008
- THTX 1993
- Country
- MRAM United States
- THTX Canada
- Employees
- MRAM N/A
- THTX N/A
- Industry
- MRAM Semiconductors
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- THTX Health Care
- Exchange
- MRAM Nasdaq
- THTX Nasdaq
- Market Cap
- MRAM 114.4M
- THTX 119.1M
- IPO Year
- MRAM 2016
- THTX N/A
- Fundamental
- Price
- MRAM $6.69
- THTX $3.16
- Analyst Decision
- MRAM Strong Buy
- THTX Hold
- Analyst Count
- MRAM 1
- THTX 1
- Target Price
- MRAM $8.00
- THTX N/A
- AVG Volume (30 Days)
- MRAM 221.1K
- THTX 1.0M
- Earning Date
- MRAM 07-30-2025
- THTX 07-09-2025
- Dividend Yield
- MRAM N/A
- THTX N/A
- EPS Growth
- MRAM N/A
- THTX N/A
- EPS
- MRAM N/A
- THTX N/A
- Revenue
- MRAM $49,110,000.00
- THTX $84,378,000.00
- Revenue This Year
- MRAM $9.48
- THTX N/A
- Revenue Next Year
- MRAM $12.85
- THTX $15.13
- P/E Ratio
- MRAM N/A
- THTX N/A
- Revenue Growth
- MRAM N/A
- THTX 2.19
- 52 Week Low
- MRAM $4.34
- THTX $1.12
- 52 Week High
- MRAM $7.02
- THTX $3.20
- Technical
- Relative Strength Index (RSI)
- MRAM 59.56
- THTX 73.38
- Support Level
- MRAM $6.44
- THTX $3.14
- Resistance Level
- MRAM $6.94
- THTX $3.20
- Average True Range (ATR)
- MRAM 0.26
- THTX 0.06
- MACD
- MRAM 0.00
- THTX 0.06
- Stochastic Oscillator
- MRAM 67.65
- THTX 94.93
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.